Anthem Biosciences Ltd. IPO

Anthem Biosciences IPO is a Rs 3,395 crore book-built issue, consisting entirely of an offer for sale of 5.96 crore shares. The IPO opens for subscription on July 14, 2025, and closes on July 16, 2025. Allotment is expected on July 17, with listing on BSE and NSE scheduled for July 21. The price band is set at Rs 540 to Rs 570 per share. Retail investors can apply for a minimum of 26 shares, requiring an investment of Rs 14,040. For sNII, the minimum application is 14 lots (364 shares) amounting to Rs 2,07,480, while bNII is 68 lots (1,768 shares). JM Financial is the lead manager and Kfin Technologies is the registrar.

Open Demat Account

Company Financials

You can get the following financial statements of Anthem Biosciences Ltd. as of now.

Anthem Biosciences IPO Details

The details about the Anthem Biosciences IPO are as follows:

  • The issue size of the IPO is Rs 3,395.00 Cr.
  • The price band for Anthem Biosciences IPO is Rs 540 to Rs 570.
  • The shares of Anthem Biosciences IPO will list on BSE and NSE on 21 July 2025.
  • The latest tentative GMP of Anthem Biosciences IPO is Rs 156.
  • The shares of Anthem Biosciences IPO are subscribed 67.42 Times.

 

Anthem Biosciences IPO Valuation

The approximate valuation of Anthem Biosciences IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 570
Existing Shares (Qty) 56.16 Cr
Market Cap Rs 32,011.2 Cr
EPS (FY25) Rs 8.07
PE Ratio 70.63x
Industry PE 81.06x

 

Anthem Biosciences IPO Issue Size

Anthem Biosciences IPO issue size is Rs 3,395.00 Cr.

Issue Amount
Fresh Issue Rs 0 Cr
Offer For Sale Rs 3,395 Cr

 

Anthem Biosciences IPO Market Lot

An individual can apply for a minimum of 1 lot of 26 shares and a maximum of 13 lots (338 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 26 Rs 14,820
Retail Maximum 13 338 Rs 1,92,660

 

Anthem Biosciences IPO Share Offer

The shares of Anthem Biosciences IPO are subscribed 67.42 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not more than 15%
Retail Individual Not more than 35%

 

Anthem Biosciences IPO GMP (Grey Market Premium)

As on GMP (Tentative)
14 July 2025 Rs 100
16 July 2025 Rs 156

Anthem Biosciences IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Anthem Biosciences IPO Dates

Find below the dates for Anthem Biosciences IPO

Schedule Date
Basis of Allotment 17 July 2025
Refunds 18 July 2025
Credit to Demat Account 18 July 2025
IPO Listing Date 21 July 2025

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 1231.26 1056.92 1417.54 1840.65 2089.31
Total Expenditure 663.7 633.88 912.53 1151.44 1238.04
Operating Profit 567.56 423.04 505.01 689.21 851.28
Other Income 48.98 85.35 70.52 109.44 182.08
Interest 12.19 8.71 9.26 9.29 6.71
Depreciation 57.76 63.7 81.49 77.94 99.57
Exceptional Items 0 61.8 0 0 -24.01
Profit Before Tax 546.59 497.78 484.77 711.42 903.07
Provision for Tax 140.6 112.11 109.99 205.24 232.51
Net Profit 405.99 385.67 374.78 506.19 670.56
Adjusted EPS (Rs.) 0.71 0.68 0.61 0.91 1.19

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 8.78 114.1 111.82 111.82 112.34
Total Reserves 1346.69 1627.52 1821.26 2361.4 3072.36
Borrowings 5.9 85.06 65.72 47.03 28.2
Other N/C liabilities 18.83 -11.18 -18.24 5.81 4.84
Current liabilities 346.05 267.61 422.26 450.18 489.47
Total Liabilities 1726.24 2083.11 2402.82 2976.23 3707.21
Assets
Net Block 329.01 448.89 477.71 624.06 612.56
Capital WIP 152.68 143.41 155.91 57.94 83.52
Intangible WIP 0 0 0 0 0
Investments 0 6.31 12.7 220.93 717.54
Loans & Advances 23.69 49.29 190.52 349.4 242.34
Other N/C Assets 0.79 0.58 0.49 149.39 158.84
Current Assets 1220.08 1434.63 1565.49 1574.52 1892.4
Total Assets 1726.24 2083.11 2402.82 2976.23 3707.21
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026
Other Income 27.73 53.8 39.92 60.63
Profit Before Tax 198.94 253.3 150.11 300.72
Tax 50.6 54.87 37.98 89.06
Profit After Tax 148.34 198.43 112.13 211.66
Adjusted EPS (Rs) 2.64 3.53 2 3.77

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 74.68 0
Dec 2025 74.69 0
Sep 2025 74.69 0
Jul 2025 74.69 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 546.59 497.78 484.77 711.42 903.07
Adjustment 47.85 26.91 37.17 36.59 21.86
Changes in Assets & Liabilities -138.1 -90.71 -237.54 -288.55 168.49
Tax Paid -123 -115 -120 -159 -204
Operating Cash Flow 333.35 318.98 164.41 300.46 889.42
Investing Cash Flow -205.78 -377.91 -191.76 -249.58 -742.27
Financing Cash Flow 180.68 52.85 -131.59 -68.47 -43.55
Net Cash Flow 308.24 -6.07 -158.95 -17.59 103.6
X